262 related articles for article (PubMed ID: 30154112)
1. Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death.
Ueki S; Tokunaga T; Melo RCN; Saito H; Honda K; Fukuchi M; Konno Y; Takeda M; Yamamoto Y; Hirokawa M; Fujieda S; Spencer LA; Weller PF
Blood; 2018 Nov; 132(20):2183-2187. PubMed ID: 30154112
[TBL] [Abstract][Full Text] [Related]
2. Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation.
Ueki S; Miyabe Y; Yamamoto Y; Fukuchi M; Hirokawa M; Spencer LA; Weller PF
Curr Allergy Asthma Rep; 2019 Jun; 19(8):35. PubMed ID: 31203469
[TBL] [Abstract][Full Text] [Related]
3. In Vivo ETosis of Human Eosinophils: The Ultrastructural Signature Captured by TEM in Eosinophilic Diseases.
Neves VH; Palazzi C; Bonjour K; Ueki S; Weller PF; Melo RCN
Front Immunol; 2022; 13():938691. PubMed ID: 35874692
[TBL] [Abstract][Full Text] [Related]
4. Galectin-10, the protein that forms Charcot-Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils.
Melo RCN; Wang H; Silva TP; Imoto Y; Fujieda S; Fukuchi M; Miyabe Y; Hirokawa M; Ueki S; Weller PF
J Leukoc Biol; 2020 Jul; 108(1):139-149. PubMed ID: 32108369
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.
Ueki S; Tokunaga T; Fujieda S; Honda K; Hirokawa M; Spencer LA; Weller PF
Curr Allergy Asthma Rep; 2016 Jul; 16(8):54. PubMed ID: 27393701
[TBL] [Abstract][Full Text] [Related]
6. Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes.
Takeda M; Ueki S; Yamamoto Y; Nara M; Fukuchi M; Nakayama K; Omori Y; Takahashi N; Hirokawa M
Asia Pac Allergy; 2020 Jul; 10(3):e24. PubMed ID: 32789109
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes.
Ueki S; Konno Y; Takeda M; Moritoki Y; Hirokawa M; Matsuwaki Y; Honda K; Ohta N; Yamamoto S; Takagi Y; Wada A; Weller PF
J Allergy Clin Immunol; 2016 Jan; 137(1):258-267. PubMed ID: 26070883
[TBL] [Abstract][Full Text] [Related]
8. Galectin-10 as a Potential Biomarker for Eosinophilic Diseases.
Tomizawa H; Yamada Y; Arima M; Miyabe Y; Fukuchi M; Hikichi H; Melo RCN; Yamada T; Ueki S
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291593
[TBL] [Abstract][Full Text] [Related]
9. Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.
Grozdanovic MM; Doyle CB; Liu L; Maybruck BT; Kwatia MA; Thiyagarajan N; Acharya KR; Ackerman SJ
J Allergy Clin Immunol; 2020 Aug; 146(2):377-389.e10. PubMed ID: 31982451
[TBL] [Abstract][Full Text] [Related]
10. Glutathione disrupts galectin-10 Charcot-Leyden crystal formation to possibly ameliorate eosinophil-based diseases such as asthma.
Na H; Sayed H; Ayala GJ; Wang X; Liu Y; Yu J; Liu T; Mayo KH; Su J
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(4):613-622. PubMed ID: 36988350
[TBL] [Abstract][Full Text] [Related]
11. How to detect eosinophil ETosis (EETosis) and extracellular traps.
Fukuchi M; Miyabe Y; Furutani C; Saga T; Moritoki Y; Yamada T; Weller PF; Ueki S
Allergol Int; 2021 Jan; 70(1):19-29. PubMed ID: 33189567
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.
Fukuchi M; Kamide Y; Ueki S; Miyabe Y; Konno Y; Oka N; Takeuchi H; Koyota S; Hirokawa M; Yamada T; Melo RCN; Weller PF; Taniguchi M
Arthritis Rheumatol; 2021 Sep; 73(9):1683-1693. PubMed ID: 33750029
[TBL] [Abstract][Full Text] [Related]
13. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
[TBL] [Abstract][Full Text] [Related]
14. Kinetic studies of galectin-10 release from eosinophils exposed to proliferating T cells.
Lingblom C; Andersson K; Wennerås C
Clin Exp Immunol; 2021 Feb; 203(2):230-243. PubMed ID: 33080067
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.
Ueki S; Ohta N; Takeda M; Konno Y; Hirokawa M
Curr Allergy Asthma Rep; 2017 May; 17(5):33. PubMed ID: 28455742
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans.
Ueki S; Melo RC; Ghiran I; Spencer LA; Dvorak AM; Weller PF
Blood; 2013 Mar; 121(11):2074-83. PubMed ID: 23303825
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil extracellular traps in eosinophilic chronic rhinosinusitis induce Charcot-Leyden crystal formation and eosinophil recruitment.
Zhang S; Wang Z
Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38426234
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
Dvorak AM; Letourneau L; Login GR; Weller PF; Ackerman SJ
Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR
Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464
[TBL] [Abstract][Full Text] [Related]
20. Charcot-Leyden crystals: An ancient but never so current discovery.
Gelardi M; Giancaspro R; Cassano M
Am J Otolaryngol; 2023; 44(4):103844. PubMed ID: 36948077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
